CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
dc.contributor.author | Lee, Cindy | en_GB |
dc.contributor.author | Guinn, Barbara-Ann | en_GB |
dc.contributor.author | Brooks, Suzanne E. | en_GB |
dc.contributor.author | Richardson, Deborah | en_GB |
dc.contributor.author | Orchard, Kim H. | en_GB |
dc.date.accessioned | 2012-05-18T08:52:25Z | |
dc.date.available | 2012-05-18T08:52:25Z | |
dc.date.issued | 2010-06 | |
dc.identifier.citation | Lee, C., Guinn, B.A., Brooks, S.E., Orchard, K. (2010) 'CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?' 149 (5):795-6 | en_GB |
dc.identifier.issn | 1365-2141 | |
dc.identifier.pmid | 20230402 | |
dc.identifier.doi | 10.1111/j.1365-2141.2010.08100.x | |
dc.identifier.uri | http://hdl.handle.net/10547/224525 | |
dc.description.sponsorship | Leukaemia and Lymphoma Research, Cancer Research U.K. | en_GB |
dc.language.iso | en | en |
dc.publisher | Wiley | en_GB |
dc.relation.url | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08100.x/abstract | en_GB |
dc.subject | CD66 | en_GB |
dc.subject | targetted radiotherapy | en_GB |
dc.subject | multiple myeloma | en_GB |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Antigens, CD | |
dc.subject.mesh | Antigens, Neoplasm | |
dc.subject.mesh | Cell Adhesion Molecules | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Multiple Myeloma | |
dc.subject.mesh | Plasma Cells | |
dc.subject.mesh | Radioimmunotherapy | |
dc.title | CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials? | en |
dc.type | Article | en |
dc.identifier.journal | British journal of haematology | en_GB |